Hypoxic Ischemic Encephalopathy Hie clinical trials

Explore recruiting hypoxic ischemic encephalopathy hie clinical trials.

Recruiting hypoxic ischemic encephalopathy hie studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypoxic Ischemic Encephalopathy Hie trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of safety, side effects and how the drug CHF6467 administrated via intranasal route is absorbed, modified and removed in healthy subjects.

Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

ACUMEN: Phase I Dose Escalation and Cohort Expansion study to affirm the safety of pharmacological doses of a novel formulation of intravenous melatonin in babies with hypoxic-ischaemic encephalopathy (HIE) to augment therapeutic hypothermia (HT) treatment; to reduce the incidence and severity of disability in babies with moderate-severe HIE.

Ireland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Effect of ALlopurinol in addition to hypothermia for hypoxicischemic Brain Injury on Neurocognitive Outcome

Germany, Italy, Norway, Spain, Finland, Netherlands +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hypoxic Ischemic Encephalopathy Hie trials by city

Hypoxic Ischemic Encephalopathy Hie in Toronto Hypoxic Ischemic Encephalopathy Hie in Vancouver Hypoxic Ischemic Encephalopathy Hie in Montreal Hypoxic Ischemic Encephalopathy Hie in Calgary Hypoxic Ischemic Encephalopathy Hie in Edmonton Hypoxic Ischemic Encephalopathy Hie in Ottawa Hypoxic Ischemic Encephalopathy Hie in Winnipeg Hypoxic Ischemic Encephalopathy Hie in Quebec City Hypoxic Ischemic Encephalopathy Hie in Hamilton Hypoxic Ischemic Encephalopathy Hie in Kitchener Hypoxic Ischemic Encephalopathy Hie in London Hypoxic Ischemic Encephalopathy Hie in Halifax Hypoxic Ischemic Encephalopathy Hie in New York Hypoxic Ischemic Encephalopathy Hie in Los Angeles Hypoxic Ischemic Encephalopathy Hie in Chicago Hypoxic Ischemic Encephalopathy Hie in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease